Dale L. Ludwig, Chief Scientific Officer at Actinium Pharmaceuticals, Inc. (ATNM), bought 10,000 shares at $0.45 ($5K) on 2018-11-19, disclosed to the SEC on 2018-11-20.
Open-market purchase of $4k ATNM by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.